Content area

|
|

Den endokrine og metaboliske kobling mellem COVID-19, diabetes og fedme

Forfatter(e)

Nina Weis1, Kristina Thorsteinsson1, Christoffer Martinussen2 & Sten Madsbad2

1) Infektionsmedicinsk Afdeling, Hvidovre Hospital, 2) Endokrinologisk Afdeling, Hvidovre Hospital

Ugeskr Læger 2020;182:V05200381

Reference: 
UgeskrLæger 2020;182:V05200381
The endocrine and metabolic link between COVID-19, diabetes and obesity

Nina Weis, Kristina Thorsteinsson, Christoffer Martinussen & Sten Madsbad

Ugeskr Læger 2020;182:V05200381

Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome corona virus 2. High age, hypertension, diabetes, and obesity are risk factors for severe COVID-19 with increased mortality. In this review, we discuss potential mechanisms by which diabetes and obesity modulate the host viral interactions and host-immune response. Glucose levels should be monitored rigorously, and patient-tailored aggressive treatment of hyperglycaemia is recommended, often with the use of insulin. Persons with diabetes and obesity are susceptible to severe outcomes from COVID-19.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Winsløw | 22/10
2 kommentarer
af Jens Meyer Svendsen | 21/10
2 kommentarer
af Sven Refslund Poulsen | 16/10
1 Kommentar
af Jens Ole Mathiesen | 16/10
1 Kommentar
af Gunnar Lauge Nielsen | 13/10
1 Kommentar
af Morten Krogh Jensen | 13/10
11 kommentarer
af Frank Østergaard Hansen | 12/10
1 Kommentar